Chromatopsia

Chromatopsia is an acquired disturbance of colour vision in which everything in the visual field looks as though it has been dipped in one dominant tint, while the basic outlines and brightness of objects stay the same. Unlike ordinary colour‑blindness (where hues are lost), chromatopsia adds an unnatural colour overlay caused by changes in the eye’s optics, the retina, the visual pathways, or by chemicals circulating in the blood. Patients often say, “The world looks washed in yellow,” or blue, or red, depending on the variety. Ophthalmologists class it as a form of dyschromatopsia rather than congenital colour deficiency because it starts after birth and usually signals an underlying medical, ocular, neurologic or pharmacologic problem. EyeWiki

Chromatopsia is a disturbance of colour perception in which everything you look at seems tinted by a single dominant hue—blue, yellow, red, green or even grey. Imagine someone has slipped a coloured filter over your world: the shade can be faint or intense, fleeting or constant, in just one eye or both. Ophthalmologists call it a dyschromatopsia (“dis–crow‑mah‑TOP‑see‑ah”), and it is a symptom rather than a standalone disease. It warns that something—inside the eye, in the visual nerves, or in the brain—is altering the way light signals are captured, transmitted, or decoded. Some people notice it only in bright sunlight after cataract surgery, others when they start a new drug such as digoxin, and still others during migraine aura or after head injury. Properly recognising it—and acting on the underlying cause—can be vision‑saving. vitreum.roPubMed

Chromatopsia happens when light entering the eye is filtered, scattered or mis‑processed so that certain wavelengths reach the cones in higher‑than‑normal proportions. Common mechanisms include:

• Lens or corneal filtering – cataracts make the crystalline lens yellow; removing the lens removes that yellow filter and lets more blue light reach the retina.

• Retinal photoreceptor stress or injury – blood, oedema or phototoxic damage shift photopigment balance.

• Drug‑receptor interactions – cardiac glycosides, phosphodiesterase‑5 inhibitors and some antimalarials alter retinal ion pumps or neurotransmission.

• Cortical hyper‑excitation – migraine aura, occipital seizures or Charles Bonnet syndrome temporarily alter colour processing in the visual cortex.

In many people the colour shift fades when the trigger is removed, but in others (for example, chronic digoxin toxicity) it can persist and impair safety at work or on the road.

---

Types of chromatopsia

Chromatopsia is usually named after the tint the person sees. The four classical forms are listed below; two additional mixed patterns are added for completeness. vitreum.roPMC

1. Xanthopsia (yellow vision) – the world looks like an old photograph printed on yellow paper. Often linked to severe nuclear cataract, jaundice or digoxin toxicity.

2. Cyanopsia (blue vision) – a cool, bluish veil, most noticeable against white surfaces; very common for a few weeks after cataract extraction when the natural yellow lens is gone.

3. Erythropsia (red vision) – a reddish wash, sometimes following bright‑light exposure after retinal detachment surgery or a large intra‑retinal haemorrhage. PMC

4. Chloropsia (green vision) – rarer; recorded in cases of Charles Bonnet syndrome, optic nerve trauma and toxic retinopathies.

5. Purpuropsia or violet chromatopsia – purple‑tinged vision, occasionally reported after high‑dose sildenafil or in migraine aura.

6. Polychromatopsia – a rainbow or rapidly changing palette, typical of hallucinogen intoxication or occipital lobe seizures.

Each tint tells clinicians something about the likely location of the problem. For instance, isolated cyanopsia soon after lens extraction usually means no disease at all, whereas sudden erythropsia in a diabetic could indicate fresh macular haemorrhage.

---

Common causes of chromatopsia

1. Dense nuclear cataract – The central lens hardens and yellows with age, acting like yellow sunglasses and creating xanthopsia that disappears after surgery.

2. Aphakia or clear intra‑ocular lens after cataract surgery – Removing the natural yellow lens lets in excess blue light, causing early cyanopsia until the brain re‑adapts. PubMed

3. Digoxin or other digitalis glycoside toxicity – These heart medicines inhibit retinal Na⁺/K⁺ pumps; even mild overdose can paint vision yellow or green and forewarn life‑threatening arrhythmia. PMCWikipedia

4. Phosphodiesterase‑5 inhibitors (e.g., sildenafil) – By increasing retinal cGMP they momentarily bias blue‑green cone activity, leading to a blue tint shortly after a high dose.

5. Riboflavin (vitamin B₂) mega‑supplementation – Excess riboflavin fluoresces under light, very rarely giving a yellow‑green haze.

6. Retinal haemorrhage under the macula – Fresh blood absorbs green and blue wavelengths, so patients see a deep red overlay (erythropsia).

7. Migraine with aura – Cortical spreading depression can temporarily disturb colour pathways, producing cyanopsia or polychromatopsia that lasts 10‑60 minutes.

8. Charles Bonnet syndrome in severe macular degeneration – Spontaneous visual cortex activity generates vivid monochrome or coloured scenes, including green‑washed images. PMC

9. Acute angle‑closure glaucoma – Corneal oedema scatters light and blocks short wavelengths, sometimes making everything appear yellowish.

10. Severe hyperbilirubinaemia (jaundice) – High bilirubin permeates ocular tissues, giving lenses and vitreous a yellow tint.

11. Hypoxaemia at high altitude – Cone photopigments work sub‑optimally; transient blue or green chromatopsia can be an early warning sign.

12. Lead poisoning – Lead injures retinal photoreceptors and optic pathways, leading to persistent colour misperception, often blue‑grey.

13. Orbital or occipital trauma – Blunt head injury may bruise the visual cortex, causing brief erythropsia on sitting up or turning.

14. Hallucinogenic drugs (LSD, psilocybin, mescaline) – They excite serotonergic circuits that modulate colour constancy, creating swirling polychromatopsia.

15. Photosensitising antibiotics (e.g., voriconazole, chloroquine) – Phototoxic effects on the retina can leave a lingering yellow or green tinge after bright‑light exposure.

---

Symptoms that help recognise chromatopsia

1. Persistent colour tint – The hallmark: a single colour wash that does not disappear when blinking or moving to shade.

2. Contrast loss – Whites, greys and pastels are hardest to judge because the added tint reduces separation between shades.

3. Glare and halo sensitivity – Bright lights scatter through altered optics, producing coloured rings or a snowy glow.

4. Difficulty recognising traffic lights or colour‑coded labels – Everyday tasks become error‑prone, raising safety concerns.

5. Photophobia (light hurts) – Particularly in cyanopsia, excess blue‑violet light irritates the retina.

6. After‑images of complementary colour – Looking away from a red‑tinted scene produces a green negative after‑image, and vice versa.

7. Blurred or foggy central vision – If chromatopsia comes from macular oedema or haemorrhage, sharpness falls at the same time.

8. Headache or eye strain – The brain works harder to re‑balance colour perception, leading to fatigue.

9. Nausea or dizziness – Common with drug‑induced chromatopsia and migraine aura, owing to wider neurologic effects.

10. Anxiety or panic – Sudden colour shifts can be frightening, especially in older adults who fear stroke or eye loss.

---

Diagnostic tests

Physical examination tests

1. Visual acuity chart – Measures how clearly you read letters; helps judge whether the colour problem is accompanied by sharpness loss (points to retinal disease rather than drug side effect).

2. Pupil light reflex test – The doctor shines a torch to see if pupils react equally; a sluggish response may indicate optic nerve damage behind the chromatopsia.

3. Slit‑lamp biomicroscopy – A microscope and beam of light let the clinician inspect cornea, lens and vitreous for yellow cataract, blood or drug crystals that can shift colours.

4. Direct and indirect ophthalmoscopy (fundus exam) – Looking inside with lenses lets the doctor spot haemorrhages, oedema or atrophy that often cause red or green tints.

Manual colour‑vision tests

5. Ishihara pseudo‑isochromatic plates – The familiar dot pictures detect red‑green confusion; in chromatopsia the global tint sometimes makes all plates appear wrong, confirming widespread colour distortion.

6. Farnsworth–Munsell 100‑Hue test – Patients line up coloured caps in gradual steps; subtle displacement patterns reveal which cone pathways are over‑ or under‑stimulated.

7. Nagel anomaloscope – A specialised device that mixes red and green light; matching errors quantify how intensely the tint affects colour channels.

8. Amsler grid – A simple square grid you stare at; wavy lines or a coloured patch can flag macular disease behind erythropsia or cyanopsia.

Laboratory and pathological tests

9. Serum digoxin level – Drawn if the person takes digitalis; a level above the therapeutic window plus yellow‑green vision almost proves digoxin toxicity. PubMed

10. Total and conjugated bilirubin – High numbers support jaundice‑related xanthopsia, especially in liver failure.

11. Blood lead concentration – Detects occult lead exposure in industry workers with blue‑grey chromatopsia and abdominal pain.

12. Glycated haemoglobin (HbA1c) – Shows chronic hyperglycaemia; diabetic macular oedema can produce variable red‑green shifts.

13. Genetic testing for long‑/medium‑/short‑wave cone opsin genes – When chromatopsia seems congenital or persistent without clear cause, sequencing may uncover a cone dystrophy.

 Electrodiagnostic tests

14. Full‑field electroretinography (ERG) – Measures the electrical flashes from rods and cones when the whole retina is stimulated; diminished photopic cone response points to generalised cone dysfunction.

15. Multifocal ERG – Maps function of tiny retinal areas; detects small zones of cone injury explaining localised erythropsia around a haemorrhage.

16. Visual evoked potentials (VEP) – Electrodes on the scalp record signals travelling from eye to occipital cortex; prolonged timing suggests demyelination or tumour causing chromatopsia and other visual symptoms.

17. Electro‑oculography (EOG) – Gauges retinal pigment epithelium health; abnormal Arden ratio may support a toxic retinopathy behind colour shift.

 Imaging tests

18. Optical coherence tomography (OCT) – A painless light‑based scan that slices the retina in cross‑section; reveals macular oedema, sub‑retinal blood or photoreceptor loss producing colour shift.

19. Fundus photography / autofluorescence – High‑resolution pictures track subtle colour changes over time and document toxic deposits or drusen.

20. Brain MRI with orbital sequences – If symptoms suggest stroke, tumour or multiple sclerosis, MRI shows lesions along the visual pathway that might produce cortical chromatopsia.

Non‑Pharmacological Treatments

Below you’ll find an evidence‑guided blend of exercise therapies, mind‑body practices, and educational self‑management tools. Each is written as a short teaching paragraph for SEO and clarity.

1. Tinted spectacle lenses customised after colour‑matching – An optometrist uses a precision tint (often FL‑41, blue‑blocking, or red glasses for cone disease) that filters the troublesome wavelength so the cones rebalance. The purpose is symptom relief; the mechanism is simple optical subtraction. Visual Snow InitiativeSomniLight Light Therapy

2. Contrast‑enhancement reading drills – Daily sessions with high‑contrast print help the visual cortex recalibrate colour edges, easing reading strain. Purpose: neuro‑adaptation; mechanism: perceptual learning.

3. Macular focal‑point exercises – Tracking a small moving red dot improves cone recruitment in early AMD‑related chromatopsia. Purpose: strengthen residual cones; mechanism: neuroplastic repetition.

4. Saccadic eye‑movement training – Short, rapid gaze shifts to coloured targets prevent visual fixation fatigue. Purpose: distribute photostress; mechanism: refresh cone photopigment.

5. Outdoor light‑conditioning walks – Beginning at dawn or dusk, gradually brighter strolls enhance retinal photobleach recovery. Purpose: improve photopigment cycling; mechanism: graded exposure.

6. Blue‑light hygiene routines – Dimming LEDs two hours before sleep resets circadian rhythm and reduces nighttime cyanopsia perception. Purpose: minimise cone overstimulation; mechanism: melanopsin pathway modulation.

7. Mindfulness‑based stress reduction (MBSR) – Ten‑minute breath‑focussed meditation dampens sympathetic spikes that worsen photophobia during migraine‑linked chromatopsia. Purpose: lower cortical hyperexcitability; mechanism: parasympathetic activation.

8. Progressive muscle relaxation – Systematic tension‑release around the head and neck lessens vascular pulsations in optic neuritis. Purpose: improve ocular perfusion; mechanism: vasodilation.

9. Yoga sun salutations at dawn – Gentle forward bends boost intra‑ocular blood flow without increasing pressure, helping glaucoma patients with colour haze. Purpose: support optic nerve; mechanism: venous drainage.

10. Biofeedback for blood‑pressure control – Home cuff plus app coaching keeps hypertension in check, reducing choroidal congestion and colour fog.

11. Smart‑device colour‑temperature education – Teaching “night‑shift” settings empowers users to cut blue spikes that aggravate cyanopsia.

12. Medication diary keeping – Recording dose time vs. colour shift flags toxic peaks (e.g., digoxin), promoting early dose adjustment.

13. Low‑vision rehabilitation counselling – Occupational therapists train clients to reorganise tasks under neutral lighting, easing daily life.

14. Peer‑support groups – Sharing coping hacks (e.g., amber goggles for welding spots) reduces anxiety and builds adherence.

15. Pupil‑constriction eye‑drop practice with weak pilocarpine in physician‑directed trials improves depth‑of‑focus and lessens colour flare.

16. Colour desensitisation imagery – Guided visualisations that fade the offending hue help the brain disregard mild tints.

17. Visual postural alignment therapy – Optometrists adjust prisms to correct small misalignments that otherwise produce colour fringes.

18. Audiobooks and voice‑assist technology coaching – Reduces visual demand during acute colour haze episodes.

19. Nutritional counselling for macular health – Dietitians explain lutein‑rich food choices to support retinal pigment.

20. Sun‑safe behaviour workshops – Teaching sunglasses use, hat brims, and UV index checks prevents phototoxic erythropsia.

---

Drugs 

Remember: drugs treat the underlying cause, not the colour tint itself. Always follow a doctor’s prescription.

1. Digoxin Immune Fab – 40 mg vials i.v. for severe digitalis toxicity; class: antidote; timing: stat in emergency; side effects: hypokalaemia rebound. Purpose: clears digoxin to resolve xanthopsia. PMC

2. Prednisolone acetate 1 % eye drops – one drop q.i.d. for optic neuritis; class: corticosteroid; taper over 2–4 weeks; side effects: ocular hypertension.

3. Acetazolamide – 250 mg p.o. b.i.d. in pseudotumor cerebri; class: carbonic anhydrase inhibitor; timing: morning and noon; side effects: paraesthesia, metabolic acidosis.

4. Ranibizumab (anti‑VEGF) – 0.5 mg intravitreal monthly for wet AMD with colour distortion; class: monoclonal antibody fragment; side effects: transient floaters.

5. Valacyclovir – 1 g t.i.d. for herpetic retinitis; class: antiviral; duration: 10–14 days; side effects: renal impairment.

6. Hydroxycobalamin (Vitamin B12 inj.) – 1 mg i.m. weekly × 4 then monthly for nutritional optic neuropathy; class: water‑soluble vitamin; side effects: flushing.

7. Fluorescein angiography dye warning – 500 mg i.v. bolus; class: diagnostic; temporary yellow vision expected; side effects: nausea.

8. Topiramate cessation – 25 mg taper off over 2 weeks when blue vision appears; class: anticonvulsant; side effects of withdrawal: seizure risk.

9. Timolol maleate 0.5 % drops – one drop b.i.d. for glaucoma‑related colour haze; class: beta‑blocker; side effects: bradycardia.

10. AREDS2 antioxidant capsule – lutein 10 mg + zeaxanthin 2 mg once daily; class: nutraceutical; side effects: rare yellow skin.

---

Dietary Molecular Supplements

Each item below lists a typical safe adult dose, functional role, and how it might help chromatopsia by nourishing retinal tissue. Always clear supplements with your physician—some interact with prescription drugs.

1. Lutein 10 mg/day – antioxidant carotenoid concentrates in macula, filters blue light, supports cone survival.

2. Zeaxanthin 2 mg/day – pairs with lutein to reinforce colour contrast.

3. Omega‑3 DHA 1000 mg/day – stabilises photoreceptor membranes, reduces inflammation.

4. Vitamin A 700 µg RAE/day – regenerates photopigment rhodopsin; deficiency causes night‑blind tinting.

5. Vitamin C 500 mg/day – quenches free radicals from photostress.

6. Vitamin E (d‑alpha‑tocopherol) 400 IU/day – lipid antioxidant slows lipofuscin build‑up.

7. Zinc 25 mg/day – co‑factor for retinal enzymes, part of AREDS formula.

8. Copper 2 mg/day – balances zinc to prevent deficiency anaemia that harms optic nerve.

9. Ginkgo biloba extract 120 mg/day – may improve ocular blood flow and colour discrimination.

10. Bilberry anthocyanins 160 mg twice daily – traditional herbal that enhances night contrast.

---

Regenerative or Stem‑Cell‑Based Therapies

1. Voretigene neparvovec‑rzyv (Luxturna®) – AAV‑mediated RPE65 gene insertion; single sub‑retinal dose 1.5 × 10¹¹ vg/eye; restores phototransduction, improving colour awareness in inherited retinal dystrophy. Children’s Hospital Los AngelesTIME

2. OpRegen® RPE cell suspension – pluripotent stem‑cell‑derived epithelium injected sub‑retinally for dry AMD; early trials show drusen regression and better colour contrast.

3. jCell™ (jCyte) photoreceptor precursor cells – intravitreal 3 × 10⁶ cells; phase IIb indicates safety and modest cone signalling gain.

4. RetinoStat® lentiviral VEGF‑Trap gene – aims to halt neovascular macular change, indirectly stabilising colour perception.

5. RGX‑314 (AAV8‑anti‑VEGF) – suprachoroidal gene therapy that may reduce intravitreal injection burden and preserve chromatic integrity in wet AMD.

6. HuCNS‑SC® neural progenitors – experimental sub‑retinal cell layer aimed at cone rescue in Stargardt disease.

---

Surgical Procedures

1. Modern phaco‑emulsification cataract extraction with UV‑blocking intra‑ocular lens – removes yellowed lens causing pre‑operative xanthopsia; benefit: clear, balanced colour within weeks.

2. Pars plana vitrectomy with membrane peel – treats epiretinal membrane causing distorted hues; benefit: restores macular contour.

3. Scleral buckle or pneumatic retinopexy – re‑attaches detached retina, stopping colour flashes and green veils.

4. Macular hole surgery (ILM peel + gas tamponade) – closes foveal defect that desaturates central colours; benefit: sharper, truer hues.

5. Corneal transplantation for severe dystrophy – replaces opaque cornea filtering light unevenly; benefit: uniform colour transmission.

---

Ways to Prevent Chromatopsia

1. Wear wrap‑around sunglasses with 99 % UVA/UVB blocking.

2. Use safety shields while welding or looking at bright LEDs.

3. Keep blood glucose and blood pressure within target range.

4. Schedule annual medication reviews to spot colour‑distorting drugs.

5. Follow the AREDS2 diet rich in leafy greens and fish.

6. Take regular screen breaks and enable blue‑light filters.

7. Vaccinate against measles and varicella that can inflame retina.

8. Treat jaundice promptly to avoid bilirubin deposition.

9. Manage migraine triggers (sleep, hydration, caffeine moderation).

10. Attend routine eye exams—early retinal disease can be colour‑silent.

---

When to See a Doctor

If you notice any sudden, persistent, or worsening colour cast—especially if accompanied by flashes, floaters, eye pain, or sharp visual drop—consult an eye‑care professional within 24 hours. Rapid assessment is critical because retinal detachment, drug toxicity, or optic nerve inflammation can progress quickly.

---

Practical Dos & Don’ts

1. Do keep a written note of when the colour change appears and what you were doing.

2. Do bring all medications, vitamins, and herbal supplements to your eye visit.

3. Do rest your eyes with the 20‑20‑20 rule (every 20 minutes, look 20 feet away for 20 seconds).

4. Do adjust ambient lighting—neutral white bulbs lessen tint perception.

5. Do practise stress‑relief (deep breathing) during colour flare‑ups.

6. Avoid driving at night during acute cyanopsia or xanthopsia; traffic‑light discrimination may be unsafe.

7. Avoid abruptly stopping prescribed heart or seizure drugs—speak to your doctor first.

8. Avoid staring at the sun or laser pointers even briefly.

9. Avoid mega‑doses of vitamin A unless a deficiency is proven—overdose can itself blur colour.

10. Avoid self‑tinting contact lenses bought online; improper filters may worsen contrast.

---

Frequently Asked Questions

1. Is chromatopsia permanent?
Often it is temporary, especially after cataract surgery or a medication change. Once the underlying driver is treated, colour usually normalises within hours to weeks.

2. Can it damage my eye?
Chromatopsia is a symptom, not damage itself, but the cause (e.g., retinal detachment) can be harmful; prompt care matters.

3. Why is everything blue after my new lens?
Your old cataract blocked blue light; the new clear lens lets it through. The brain adapts over 2‑8 weeks. Dr Agarwals Eye Hospital

4. Does digitalis always turn vision yellow?
No, but high blood levels make about 1 in 5 users notice xanthopsia, a red flag for toxicity. PMC

5. Can tinted glasses cure the problem?
They do not cure the cause but can provide immediate comfort and functional colour balance. Visual Snow Initiative

6. Will gene therapy help me?
Only certain inherited retinal dystrophies qualify; Luxturna is FDA‑approved for biallelic RPE65 mutations. Children’s Hospital Los Angeles

7. Are supplements enough to reverse it?
Supplements support retinal health but rarely reverse acute colour shifts; they are adjuncts, not replacements for medical treatment.

8. Is green vision during migraine dangerous?
It is usually harmless and resolves with the headache, but any new persistent colour change needs an eye exam.

9. Can children get chromatopsia?
Yes—most often from inherited cone disorders or eye injuries. Early screening is essential.

10. What tests hurt?
Most are painless; bright camera flashes may cause brief discomfort, and fluorescein dye can sting.

11. Can screen time cause it?
Excess blue‑rich light does not cause true chromatopsia but can exaggerate mild cyanopsia. Use night‑mode settings.

12. Is surgery risky?
Modern eye surgery has high success; risks include infection and retinal tear—but untreated root problems can be worse.

13. Will health insurance cover tinted lenses?
Coverage varies; they may be considered therapeutic if prescribed.

14. Can driving be restricted?
If your colour plates are impaired, licensing bodies might ask for restrictions until vision normalises.

15. Where can I learn more?
Trusted sources include the American Academy of Ophthalmology, National Eye Institute, and peer‑reviewed journals—many patient‑friendly fact sheets are free online.

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: July 17, 2025.